Skip to main content
Premium Trial:

Request an Annual Quote

Israeli Protein Separation Startup Obtains $14 Million in Financing

NEW YORK, March 5 – Proteologics, a proteomics startup in Rehovot, Israel, has obtained $14 million in financing from venture capital firms, the company said Monday.

Concord Ventures, also based in Israel, led the financing with $9 million, with U.S .Venture Capital firm ABS Ventures and the Giza Fund, one of Israel's largest venture capital groups, supplying the remainder.

Proteologics is hoping to commercialize a technology for separating proteins—specifically membrane and high molecular weight hydrophobic proteins—based on the research of two physicists working in Novosibirsk, Russia, said Pennina Langer Safer, a principal with Concord Ventures.

“To the best of my knowledge, they are the only ones with the technology for this kind of protein separation,” said Safer.

Membrane proteins are important as drug targets because they regulate access to the interior of the cell. With most existing technologies, these proteins are difficult to isolate, added Safer.

Proteologics' separation technique is compatible with existing 2-D gel separation technology, including mass spectrometry systems, said Safer.

The company currently has about 25 employees, and has plans to develop its own proprietary drug discovery program, in addition to finding strategic partners, Safer said.

“What excited us is that they’ve taken some physics and chemistry-based technology and applied it to solving biological problems,” Safer said.

Proteologics was not immediately available for comment.  

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.